ATE99935T1 - Injektionsloesungen. - Google Patents

Injektionsloesungen.

Info

Publication number
ATE99935T1
ATE99935T1 AT89308352T AT89308352T ATE99935T1 AT E99935 T1 ATE99935 T1 AT E99935T1 AT 89308352 T AT89308352 T AT 89308352T AT 89308352 T AT89308352 T AT 89308352T AT E99935 T1 ATE99935 T1 AT E99935T1
Authority
AT
Austria
Prior art keywords
compound
dissolving
injection solutions
group
fluorinated
Prior art date
Application number
AT89308352T
Other languages
English (en)
Inventor
Yasushi Mikura
Akihiro Nagai
Hisayoshi Shimizu
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE99935T1 publication Critical patent/ATE99935T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89308352T 1988-08-18 1989-08-17 Injektionsloesungen. ATE99935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20510088 1988-08-18
EP89308352A EP0356143B1 (de) 1988-08-18 1989-08-17 Injektionslösungen

Publications (1)

Publication Number Publication Date
ATE99935T1 true ATE99935T1 (de) 1994-01-15

Family

ID=16501418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89308352T ATE99935T1 (de) 1988-08-18 1989-08-17 Injektionsloesungen.

Country Status (9)

Country Link
EP (1) EP0356143B1 (de)
KR (1) KR900002774A (de)
AT (1) ATE99935T1 (de)
CA (1) CA1333775C (de)
DE (1) DE68912238T2 (de)
DK (1) DK399389A (de)
ES (1) ES2062015T3 (de)
HU (1) HU204434B (de)
PT (1) PT91490B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52479A1 (en) * 1992-07-28 1998-09-28 Astra Ab Injection and injection kit containing omeprazole and its analogs
TW280770B (de) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
EP0919231A1 (de) * 1997-10-15 1999-06-02 Biogenesis, S.A. Injizierbare parasitizide Zusammensetzung und Verfahren zur Herstellung
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
WO2002013789A1 (en) * 2000-08-15 2002-02-21 H. Lundbeck A/S Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]
EP1310252A4 (de) 2000-08-18 2009-06-10 Takeda Pharmaceutical Injektionen
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
CA2445513A1 (en) * 2001-09-18 2003-03-27 Zeria Pharmaceutical Co., Ltd. Benzimidazole derivatives
KR100467100B1 (ko) * 2002-03-20 2005-01-24 일양약품주식회사 2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
CN101129368B (zh) * 2007-08-23 2012-10-10 常州市第四制药厂有限公司 含有兰索拉唑的冻干粉针
CN112353766A (zh) * 2020-10-27 2021-02-12 马鞍山丰原制药有限公司 一种兰索拉唑冻干制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (de) * 1968-10-21 1971-06-03
FR2542982B1 (fr) * 1983-03-23 1985-06-28 Vestra Union Sa Machine semi-automatique pour l'alignement des dessins des rabats de poches sur un devant de veston, et l'empilage automatique des pieces positionnees
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production

Also Published As

Publication number Publication date
PT91490A (pt) 1990-03-08
ES2062015T3 (es) 1994-12-16
EP0356143A1 (de) 1990-02-28
DK399389D0 (da) 1989-08-14
HU204434B (en) 1992-01-28
DE68912238T2 (de) 1994-07-14
DE68912238D1 (de) 1994-02-24
CA1333775C (en) 1995-01-03
EP0356143B1 (de) 1994-01-12
HUT52956A (en) 1990-09-28
PT91490B (pt) 1995-05-04
KR900002774A (ko) 1990-03-23
DK399389A (da) 1990-02-19

Similar Documents

Publication Publication Date Title
DE68912238D1 (de) Injektionslösungen.
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
SE8303911D0 (sv) Jodvinylalkoholforening och forfartande for framstellning av densamma
KR920018024A (ko) 피페리딘 유도체
DE3585763D1 (de) Acrylamid-derivate.
KR960010635A (ko) 약제학적 화합물
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
FI873059A0 (fi) Insprutningsfaerdig, vattenhaltig, alkalisk injektionsloesning av torasemid och foerfarande foer framstaellning av densamma.
ES2064856T3 (es) Composiciones farmaceuticas que contienen compuestos triciclicos.
DE3879258D1 (de) Praeparat gegen ulcus.
JPS57136567A (en) N-2-hydroxy-3-substituted piperidine compound
GB1469521A (en) Antimicrobial preparations
JPS6440467A (en) Novel substituted diphenylimidazole derivative
ES2109244T3 (es) Medicamentos que contienen compuestos de 3,7-diazabiciclo(3,3,1)nonano.
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
GB2104515B (en) Sulphimines
KR840009102A (ko) 치환된 이소퀴놀린 유도체의 제조방법
JPS5764683A (en) 2-(substituted phenyl)-5-alkylthiazolidin-4-one and remedy for pepticulcer containing said compound as active component
JPS5414956A (en) Novel 3-amino-4-homoisotwistan derivative
JPS5754177A (ja) Chikanchiazoorujudotai
KR880006177A (ko) 구아니디노 메틸벤조산 유도체
JPS572278A (en) Dibenzoxazepin derivative
ATE18554T1 (de) Optisch aktive imidazolylpropanol-verbindungen und deren herstellung und anwendung.
KR870001181A (ko) 시클로펜탄 유도체의 제조방법
FR2290203A1 (fr) 10,11-dihydro-3-carboxycyproheptadine et son n-oxyde

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee